The DOI matches its Crossref record; 671 of the 671 references it cites were found in a registry or an index.
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Open accessAbstract
Proliferation is an important part of cancer development and progression. This is manifest by altered expression and/or activity of cell cycle related proteins. Constitutive activation of many signal transduction pathways also stimulates cell growth. Early steps in tumor development are associated with a fibrogenic response and the development of a hypoxic environment which favors the survival and proliferation of cancer stem cells. Part of the survival strategy of cancer stem cells may manifested by alterations in cell metabolism. Once tumors appear, growth and metastasis may be supported by overproduction of appropriate hormones (in hormonally dependent cancers), by promoting angiogenesis, by undergoing epithelial to mesenchymal transition, by triggering autophagy, and by taking cues from surrounding stromal cells. A number of natural compounds (e.g., curcumin, resveratrol, indole-3-carbinol, brassinin, sulforaphane, epigallocatechin-3-gallate, genistein, ellagitannins, lycopene and quercetin) have been found to inhibit one or more pathways that contribute to proliferation (e.g., hypoxia inducible factor 1, nuclear factor kappa B, phosphoinositide 3 kinase/Akt, insulin-like growth factor receptor 1, Wnt, cell cycle associated proteins, as well as androgen and estrogen receptor signaling). These data, in combination with bioinformatics analyses, will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Items 201–400 of 671
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
Fox, C. J., Hammerman, P. S., Cinalli, R. M., Master, S. R., Chodosh, L. A., & Thompson, C. B. (2003) · Genes & Development · doi:10.1101/gad.1105003 · Cited by 336
Kajita, M., McClinic, K. N., & Wade, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7559-7566.2004 · Cited by 333
Bortezomib for the Treatment of Mantle Cell Lymphoma
Kane, R. C., Dagher, R., Farrell, A., Ko, C.-W., Sridhara, R., Justice, R., & Pazdur, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0871 · Cited by 332
Roles of the Akt/mTOR/p70S6K and ERK1/2 Signaling Pathways in Curcumin-Induced Autophagy
Shinojima, N., Yokoyama, T., Kondo, Y., & Kondo, S. (2007) · Autophagy · doi:10.4161/auto.4916 · Cited by 331
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Yang, L., Xie, G., Fan, Q., & Xie, J. (2010) · Oncogene · doi:10.1038/onc.2009.392 · Cited by 331
Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prévost, G., Zimber, A., Ouelaa, R., Bracke, M., De Wever, O., & Gespach, C. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.07.001 · Cited by 322
Krop, I., Demuth, T., Guthrie, T., Wen, P. Y., Mason, W. P., Chinnaiyan, P., Butowski, N., Groves, M. D., Kesari, S., Freedman, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1540 · Cited by 318
Qiang, L., Wu, T., Zhang, H.-W., Lu, N., Hu, R., Wang, Y.-J., Zhao, L., Chen, F.-H., Wang, X.-T., You, Q.-D., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.95 · Cited by 313
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
Kumar, S. M., Liu, S., Lu, H., Zhang, H., Zhang, P. J., Gimotty, P. A., Guerra, M., Guo, W., & Xu, X. (2012) · Oncogene · doi:10.1038/onc.2011.656 · Cited by 308
Pratheeshkumar, P., Budhraja, A., Son, Y.-O., Wang, X., Zhang, Z., Ding, S., Wang, L., Hitron, A., Lee, J.-C., Xu, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047516 · Cited by 307
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 306
Schiff, R., Massarweh, S. A., Shou, J., & Osborne, C. K. (2003) · PubMed · Cited by 304
Hu, Y., Lu, W., Chen, G., Wang, P., Chen, Z., Zhou, Y., Ogasawara, M., Trachootham, D., Feng, L., Pelicano, H., et al. (2012) · Cell Research · doi:10.1038/cr.2011.145 · Cited by 304
Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Xu, N., Lao, Y., Zhang, Y., & Gillespie, D. A. (2012) · Journal of Oncology · doi:10.1155/2012/951724 · Cited by 302
Martínez‐Chantar, M. L., Vázquez‐Chantada, M., Ariz, U., Martínez, N., Varela, M., Luka, Z., Capdevila, A., Rodríguez, J., Aransay, A. M., Matthiesen, R., et al. (2008) · Hepatology · doi:10.1002/hep.22159 · Cited by 302
The multiple roles of autophagy in cancer
Rosenfeldt, M. T., & Ryan, K. M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr031 · Cited by 300
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Bao, B., Ali, S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., Kong, D., Ahmad, A., Li, Y., Padhye, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2182 · Cited by 297
Self-citationShan, J., Shen, J., Liu, L., Xia, F., Xu, C., Duan, G., Xu, Y., Ma, Q., Yang, Z., Zhang, Q., et al. (2012) · Hepatology · doi:10.1002/hep.25745 · Cited by 296
Fu, Y., Chang, H., Peng, X., Bai, Q., Yi, L., Zhou, Y., Zhu, J., & Mi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102535 · Cited by 295
Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma
Fan, Q.-W., Cheng, C., Hackett, C., Feldman, M., Houseman, B. T., Nicolaides, T., Haas-Kogan, D., James, C. D., Oakes, S. A., Debnath, J., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2001017 · Cited by 295
Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., & Kurzrock, R. (2004) · Cancer · doi:10.1002/cncr.20605 · Cited by 289
Shioiri, M., Shida, T., Koda, K., Oda, K., Seike, K., Nishimura, M., Takano, S., & Miyazaki, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603193 · Cited by 287
Duce, A. M., Ortíz, P., Cabrero, C., & Mato, J. M. (1988) · Hepatology · doi:10.1002/hep.1840080113 · Cited by 286
Mimeault, M., & Batra, S. K. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0066 · Cited by 285
Stimulation of autophagy by the p53 target gene Sestrin2
Maiuri, M. C., Malik, S. A., Morselli, E., Kepp, O., Criollo, A., Mouchel, P.-L., Carnuccio, R., & Kroemer, G. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8498 · Cited by 278
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Fang, J. S., Gillies, R. D., & Gatenby, R. A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.011 · Cited by 277
Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A
Martínez‐Chantar, M. L., Corrales, F. J., Martínez‐Cruz, L. A., García‐Trevijano, E. R., Huang, Z., Chen, L., Kanel, G., Avila, M. A., Mato, J. M., & Lu, S. C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0078fje · Cited by 277
The p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppression
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2004) · The Journal of Medical Investigation · doi:10.2152/jmi.51.146 · Cited by 276
Li, M., Zhang, Z., Hill, D. L., Wang, H., & Zhang, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3066 · Cited by 274
Shehzad, A., Ha, T., Subhan, F., & Lee, Y. S. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0188-1 · Cited by 271
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Tuel-Ahlgren, L., Chelstrom, L. M., Burkhardt, A., Bolen, J., & Myers, D. E. (1995) · Science · doi:10.1126/science.7531365 · Cited by 271
NF-κB2 Is a Putative Target Gene of Activated Notch-1 via RBP-Jκ
Oswald, F., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2077 · Cited by 269
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
Wang, H., Bian, S., & Yang, C. S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr218 · Cited by 261
New Perspectives of Curcumin in Cancer Prevention
Park, W., Amin, A. R. M. R., Chen, Z. G., & Shin, D. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0410 · Cited by 260
Self-citationRole of Notch and its oncogenic signaling crosstalk in breast cancer
Guo, S., Liu, M., & Gonzalez-Perez, R. R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.12.002 · Cited by 260
Self-citationLeone, M., Zhai, D., Sareth, S., Kitada, S., Reed, J. C., & Pellecchia, M. (2003) · PubMed · Cited by 259
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
Hasima, N., & Ozpolat, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.467 · Cited by 257
Barnes, S., Peterson, T. G., & Coward, L. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590823 · Cited by 257
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Niu, Y., Altuwaijri, S., Lai, K.-P., Wu, C.-T., Ricke, W. A., Messing, E. M., Yao, J., Yeh, S., & Chang, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804700105 · Cited by 256
Virgili, F., & Marino, M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.001 · Cited by 250
Self-citationDivya, C. S., & Pillai, M. R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20170 · Cited by 248
Holcombe, R. F., Nguyen, A., Martinez, Stamos, M. J., Moyer, M. P., Planutis, K., Hope, & Holcombe, R. F. (2009) · Cancer Management and Research · doi:10.2147/cmar.s4544 · Cited by 248
Self-citationRole of insulin-like growth factor 1 receptor signalling in cancer
Larsson, O., Girnita, A., & Girnita, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602627 · Cited by 246
Vanamala, J., Reddivari, L., Radhakrishnan, S., & Tarver, C. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-238 · Cited by 242
Yalcin, A., Clem, B. F., Simmons, A., Lane, A., Nelson, K., Clem, A. L., Brock, E., Siow, D., Wattenberg, B., Telang, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016816 · Cited by 242
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Bansal, T., Jaggi, M., Khar, R., & Talegaonkar, S. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rc77 · Cited by 238
Targeting autophagy during cancer therapy to improve clinical outcomes
Levy, J. M. M., & Thorburn, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.009 · Cited by 237
Wolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 236
Signaling regulation of genomic and nongenomic functions of estrogen receptors
Acconcia, F., & Kumar, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.018 · Cited by 231
Mechanisms of Cancer Prevention by Green and Black Tea Polyphenols
Ann Beltz, L., Kay Bayer, D., Lynn Moss, A., & Mitchell Simet, I. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778226468 · Cited by 231
Multitargeted therapy of cancer by ellagitannins
Heber, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.043 · Cited by 227
Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., & Goel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057218 · Cited by 226
Zhu, M., & Kyprianou, N. (2010) · The FASEB Journal · doi:10.1096/fj.09-136994 · Cited by 226
Hypoxia and energetic tumour metabolism
Brahimi-Horn, M. C., Bellot, G., & Pouysségur, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.006 · Cited by 226
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225
Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?
Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2010) · Toxins · doi:10.3390/toxins2040517 · Cited by 225
Tumor hypoxia as a driving force in genetic instability
Luoto, K. R., Kumareswaran, R., & Bristow, R. G. (2013) · Genome Integrity · doi:10.1186/2041-9414-4-5 · Cited by 223
Expression of Snail protein in tumor–stroma interface
Francí, C., Takkunen, M., Dave, N., Alameda, F., Gómez, S., Rodríguez, R., Escrivà, M., Montserrat-Sentís, B., Baró, T., Garrido, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209519 · Cited by 220
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
Yang, J., Cao, Y., Sun, J., & Zhang, Y. (2010) · Medical Oncology · doi:10.1007/s12032-009-9344-3 · Cited by 219
Adams, L. S., Zhang, Y., Seeram, N. P., Heber, D., & Chen, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0225 · Cited by 218
Self-citationGenome-wide Dissection of MicroRNA Functions and Cotargeting Networks Using Gene Set Signatures
Tsang, J. S., Ebert, M. S., & van Oudenaarden, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.007 · Cited by 217
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y.-H., Huang, H.-Y., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217
Nguyen, A. V., Martinez, M. E., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., & Holcombe, R. F. (2009) · PubMed Central · Cited by 216
Self-citationHypoxia and adaptive landscapes in the evolution of carcinogenesis
Gillies, R. J., & Gatenby, R. A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9065-z · Cited by 215
Jacques, T. S., Swales, A., Brzozowski, M. J., Henriquez, N. V., Linehan, J. M., Mirzadeh, Z., O' Malley, C., Naumann, H., Alvarez‐Buylla, A., & Brandner, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.327 · Cited by 214
Takada, Y., Ichikawa, H., Badmaev, V., & Aggarwal, B. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3127 · Cited by 214
Meng, Q., Xia, C., Fang, J., Rojanasakul, Y., & Jiang, B.-H. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.019 · Cited by 214
Chang, C., Lee, S. O., Yeh, S., & Chang, T. M. (2014) · Oncogene · doi:10.1038/onc.2013.274 · Cited by 213
Delmas, D., Rébé, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., & Solary, E. (2004) · Oncogene · doi:10.1038/sj.onc.1208086 · Cited by 212
Ilic, N., Utermark, T., Widlund, H. R., & Roberts, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108237108 · Cited by 211
Pagliacci, M. C., Smacchia, M., Migliorati, G., Grignani, F., Riccardi, C., & Nicoletti, I. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00262-4 · Cited by 211
Choo, A. Y., & Blenis, J. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7659 · Cited by 210
Shih, J.-Y., Tsai, M.-F., Chang, T.-H., Chang, Y.-L., Yuan, A., Yu, C.-J., Lin, S.-B., Liou, G.-Y., Lee, M.-L., Chen, J. J. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0687 · Cited by 210
Rausch, V., Liu, L., Kallifatidis, G., Baumann, B., Mattern, J., Gladkich, J., Wirth, T., Schemmer, P., Büchler, M. W., Zöller, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0066 · Cited by 209
Patel, B. B., Sengupta, R., Qazi, S., Vachhani, H., Yu, Y., Rishi, A. K., & Majumdar, A. P. N. (2008) · International Journal of Cancer · doi:10.1002/ijc.23097 · Cited by 208
Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate
Imamov, O., Morani, A., Shim, G.-J., Omoto, Y., Thulin-Andersson, C., Warner, M., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403041101 · Cited by 208
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
Osipo, C., Patel, P., Rizzo, P., Clementz, A. G., Hao, L., Golde, T. E., & Miele, L. (2008) · Oncogene · doi:10.1038/onc.2008.149 · Cited by 206
Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts
Hartman, J., Lindberg, K., Morani, A., Inzunza, J., Ström, A., & Gustafsson, J.-A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0017 · Cited by 206
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
Fang, J., Ding, M., Yang, L., Liu, L.-Z., & Jiang, B.-H. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.025 · Cited by 205
Mechanisms by which IGF-I May Promote Cancer
Grimberg, A. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.678 · Cited by 204
Kim, J., Zhang, X., Rieger-Christ, K. M., Summerhayes, I. C., Wazer, D. E., Paulson, K. E., & Yee, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513378200 · Cited by 203
Tang, S., Fu, J., Nall, D., Rodova, M., Shankar, S., & Srivastava, R. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.26323 · Cited by 203
Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., & Zhu, B. (2012) · STEM CELLS · doi:10.1002/stem.1194 · Cited by 202
Schneider, Y., Duranton, B., Goss, F., Schleiffer, R., Seiler, N., & Raul, F. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc391_14 · Cited by 202
Δn89β-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland
Imbert, A., Eelkema, R., Jordan, S., Feiner, H., & Cowin, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.555 · Cited by 199
Hassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., Hosokawa, H., & Nagayama, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.891 · Cited by 195
Squires, M. S., Hudson, E. A., Howells, L., Sale, S., Houghton, C. E., Jones, J. L., Fox, L. H., Dickens, M., Prigent, S. A., & Manson, M. M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01517-4 · Cited by 194
Effects of Lycopene Supplementation in Patients with Localized Prostate Cancer
Kucuk, O., Sarkar, F. H., Djuric, Z., Sakr, W., Pollak, M. N., Khachik, F., Banerjee, M., Bertram, J. S., & Wood, D. P. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701007 · Cited by 193
Kundu, J. K., Shin, Y. K., & Surh, Y.-J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.005 · Cited by 193
Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer
Ślusarz, A., Shenouda, N. S., Sakla, M. S., Drenkhahn, S. K., Narula, A. S., MacDonald, R. S., Besch-Williford, C. L., & Lubahn, D. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3012 · Cited by 193
Dietary Polyphenols, Inflammation, and Cancer
Guo, W., Kong, E., & Meydani, M. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285098 · Cited by 191
Escrivà, M., Peiró, S., Herranz, N., Villagrasa, P., Dave, N., Montserrat-Sentís, B., Murray, S. A., Francí, C., Gridley, T., Virtanen, I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02061-07 · Cited by 191
Sansone, P., Storci, G., Giovannini, C., Pandolfi, S., Pianetti, S., Taffurelli, M., Santini, D., Ceccarelli, C., Chieco, P., & Bonafé, M. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0442 · Cited by 190
The biology of breast carcinoma
Keen, J. C., & Davidson, N. E. (2003) · Cancer · doi:10.1002/cncr.11126 · Cited by 189
Cancer Genomics: Technology, Discovery, and Translation
Tran, B., Dancey, J. E., Kamel-Reid, S., McPherson, J. D., Bedard, P. L., Brown, A. M. K., Zhang, T., Shaw, P., Onetto, N., Stein, L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2316 · Cited by 188
Benitez, D. A., Pozo‐Guisado, E., Alvarez‐Barrientos, A., Fernandez‐Salguero, P. M., & Castellón, E. A. (2007) · Journal of Andrology · doi:10.2164/jandrol.106.000968 · Cited by 186
Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts
Bhattacharyya, S., Md Sakib Hossain, D., Mohanty, S., Sankar Sen, G., Chattopadhyay, S., Banerjee, S., Chakraborty, J., Das, K., Sarkar, D., Das, T., et al. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.11 · Cited by 186
Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1
Bae, M.-K., Kim, S.-H., Jeong, J.-W., Lee, Y., Kim, H.-S., Kim, S.-R., Yun, I., Bae, S.-K., & Kim, K.-W. (2006) · Oncology Reports · doi:10.3892/or.15.6.1557 · Cited by 186
Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
Hershko, D. D. (2008) · Cancer · doi:10.1002/cncr.23317 · Cited by 185
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells
Spiotto, M. T., & Chung, T. D. K. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000215)42:3<186::aid-pros4>3.0.co;2-e · Cited by 184
Killian, P. H., Kronski, E., Michalik, K. M., Barbieri, O., Astigiano, S., Sommerhoff, C. P., Pfeffer, U., Nerlich, A. G., & Bachmeier, B. E. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs312 · Cited by 183
Pérez-Losada, J., Sánchez-Martı́n, M., Rodrı́guez-Garcı́a, A., Sánchez, M. L., Orfao, A., Flores, T., & Sánchez-Garcı́a, I. (2002) · Blood · doi:10.1182/blood.v100.4.1274.h81602001274_1274_1286 · Cited by 182
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
Curtin, J. C., & Lorenzi, M. V. (2010) · Oncotarget · doi:10.18632/oncotarget.191 · Cited by 182
Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells
Han, J., Hou, W., Goldstein, L. A., Lu, C., Stolz, D. B., Yin, X.-M., & Rabinowich, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710169200 · Cited by 181
NF-κB, stem cells and breast cancer: the links get stronger
Shostak, K., & Chariot, A. (2011) · Breast Cancer Research · doi:10.1186/bcr2886 · Cited by 180
Bao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
Self-citationLi, X., & Fan, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0157 · Cited by 179
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Heavey, S., O’Byrne, K. J., & Gately, K. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.08.006 · Cited by 178
p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
Wander, S. A., Zhao, D., & Slingerland, J. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0752 · Cited by 178
Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats
SHIN, S., CHOI, J., & LI, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.028 · Cited by 176
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Rapisarda, A., & Melillo, G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.64 · Cited by 176
Knutson, M. D., & Leeuwenburgh, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00109.x · Cited by 176
Tirkey, N., Kaur, G., Vij, G., & Chopra, K. (2005) · BMC Pharmacology · doi:10.1186/1471-2210-5-15 · Cited by 176
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175
Bilir, B., Kucuk, O., & Moreno, C. S. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-280 · Cited by 175
Gallahan, D., Jhappan, C., Robinson, G. W., Hennighausen, L. G., Sharp, R., Kordon, E. C., Callahan, R., Merlino, G. T., & Smith, G. H. (1996) · PubMed · Cited by 175
Function of the Zinc-Finger Transcription Factor SNAI2 in Cancer and Development
Cobaleda, C., Pérez-Caro, M., Vicente-Dueñas, C., & Sánchez-García, I. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130146 · Cited by 174
Cheng, J., Watkins, S. C., & Walker, W. H. (2007) · Endocrinology · doi:10.1210/en.2006-1465 · Cited by 172
Baumgarten, S. C., & Frasor, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1302 · Cited by 172
Adipocyte is a non-trivial, dynamic partner of breast cancer cells
Tan, J., Buache, E., Chenard, M.-P., Dali-Youcef, N., & Rio, M.-C. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113365jt · Cited by 171
PAN, H., ZHOU, W., HE, W., LIU, X., DING, Q., LING, L., ZHA, X., & WANG, S. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.990 · Cited by 171
Jagtap, S., Meganathan, K., Wagh, V., Winkler, J., Hescheler, J., & Sachinidis, A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787909578 · Cited by 171
Srivastava, R. K., Chen, Q., Siddiqui, I., Sarva, K., & Shankar, S. (2007) · Cell Cycle · doi:10.4161/cc.6.23.4951 · Cited by 170
Song, Z., Yue, W., Wei, B., Wang, N., Li, T., Guan, L., Shi, S., Zeng, Q., Pei, X., & Chen, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017687 · Cited by 170
The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer
Abel, E. V., Kim, E. J., Wu, J., Hynes, M., Bednar, F., Proctor, E., Wang, L., Dziubinski, M. L., & Simeone, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091983 · Cited by 169
Nonn, L., Duong, D., & Peehl, D. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl241 · Cited by 169
Brechbiel, J., Miller-Moslin, K., & Adjei, A. A. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.02.003 · Cited by 167
Bishayee, A., & Dhir, N. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.11.015 · Cited by 167
Gonzalez-Perez, R. R., Xu, Y., Guo, S., Watters, A., Zhou, W., & Leibovich, S. J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.003 · Cited by 167
Self-citationShao, Z., Alpaugh, M. L., Fontana, J. A., & Barsky, S. H. (1998) · Journal of Cellular Biochemistry · Cited by 164
Yaguchi, T., Goto, Y., Kido, K., Mochimaru, H., Sakurai, T., Tsukamoto, N., Kudo-Saito, C., Fujita, T., Sumimoto, H., & Kawakami, Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102282 · Cited by 163
The Difficulty of Targeting Cancer Stem Cell Niches
LaBarge, M. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2933 · Cited by 162
Lee-Chang, C., Bodogai, M., Martin-Montalvo, A., Wejksza, K., Sanghvi, M., Moaddel, R., de Cabo, R., & Biragyn, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300606 · Cited by 162
Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., & Ralhan, R. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.06.012 · Cited by 161
Mosieniak, G., Adamowicz, M., Alster, O., Jaskowiak, H., Szczepankiewicz, A. A., Wilczynski, G. M., Ciechomska, I. A., & Sikora, E. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.05.004 · Cited by 161
Targeting AMPK: A new therapeutic opportunity in breast cancer
Hadad, S. M., Fleming, S., & Thompson, A. M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.007 · Cited by 161
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.
Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., & Evers, B. M. (2009) · PubMed · Cited by 161
Keerthivasan, S., Aghajani, K., Dose, M., Molinero, L., Khan, M. W., Venkateswaran, V., Weber, C., Emmanuel, A. O., Sun, T., Bentrem, D. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007607 · Cited by 161
Li, S.-H., Fu, J., Watkins, D. N., Srivastava, R. K., & Shankar, S. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1493-6 · Cited by 158
Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review
Fulda, S., & Debatin, K. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.03.007 · Cited by 158
Lin, H., Shih, A., Davis, F. B., Tang, H.-Y., Martino, L. J., Bennett, J. A., & Davis, P. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64739-8 · Cited by 157
Mudd, S. H., Cerone, R., Schiaffino, M. C., Fantasia, A. R., Minniti, G., Caruso, U., Lorini, R., Watkins, D., Matiaszuk, N. V., Rosenblatt, D. S., et al. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010577512912 · Cited by 153
Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis
Carew, J. S., Espitia, C. M., Esquivel, J., Mahalingam, D., Kelly, K. R., Reddy, G., Giles, F. J., & Nawrocki, S. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151324 · Cited by 153
Endocrine-disrupting chemicals as modulators of sex steroid synthesis
Whitehead, S. A., & Rice, S. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.09.003 · Cited by 152
Kang, J., Sergio, C. M., Sutherland, R. L., & Musgrove, E. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-32 · Cited by 152
The VHL tumor suppressor and HIF: insights from genetic studies in mice
Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402313 · Cited by 151
Fan, X., & Eberhart, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2264 · Cited by 151
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 149
Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
Oishi, N., & Wang, X. W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.517 · Cited by 149
Wang, X., Yue, P., Chan, C. B., Ye, K., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Fu, H., Khuri, F. R., & Sun, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00760-07 · Cited by 149
Reinmuth, N., Liu, W., Fan, F., Jung, Y. D., Ahmad, S. A., Stoeltzing, O., Bucana, C. D., Radinsky, R., & Ellis, L. M. (2002) · PubMed · Cited by 149
Nakamura, Y., Yogosawa, S., Izutani, Y., Watanabe, H., Otsuji, E., & Sakai, T. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-100 · Cited by 149
Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer
Frasor, J. M., Weaver, A., Pradhan, M., Dai, Y., Miller, L. D., Lin, C., & Stanculescu, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2608 · Cited by 148
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 146
Kimura, A., Ohmichi, M., Kawagoe, J., Kyo, S., Mabuchi, S., Takahashi, T., Ohshima, C., Arimoto‐Ishida, E., Nishio, Y., Inoue, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207582 · Cited by 146
Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells
Hirata, H., Ueno, K., Nakajima, K., Tabatabai, Z. L., Hinoda, Y., Ishii, N., & Dahiya, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.173 · Cited by 146
Guo, L., Chen, X., Hu, Y., Yu, Z., Wang, D., & Liu, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4731 · Cited by 144
Zheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 144
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α
Gort, E. H., van Haaften, G. W., Verlaan-Klink, I., Groot, A. J., Plasterk, R. H. A., Shvarts, A., Suijkerbuijk, K. P. M., van Laar, T., van der Wall, E., Raman, V., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210795 · Cited by 143
Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway
Tang, F., Shih, C.-J., Cheng, L., Ho, H., & Chen, H. C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700272 · Cited by 142
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
Guo, S., Liu, M., Wang, G., Torroella‐Kouri, M., & Gonzalez-Perez, R. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.002 · Cited by 142
Self-citationHypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 141
The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells
Lacorazza, H. D., Yamada, T., Liu, Y., Miyata, Y., Sivina, M., Nunes, J., & Nimer, S. D. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.017 · Cited by 141
Prakobwong, S., Gupta, S. C., Kim, J. H., Sung, B., Pinlaor, P., Hiraku, Y., Wongkham, S., Sripa, B., Pinlaor, S., & Aggarwal, B. B. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr032 · Cited by 141
Lung cancer stem cells: tools and targets to fight lung cancer
Eramo, A., Haas, T. L., & Maria, R. D. (2010) · Oncogene · doi:10.1038/onc.2010.207 · Cited by 140
Leow, P., Tian, Q., Ong, Z. Y., Yang, Z., & Ee, P. L. R. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9311-z · Cited by 139
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network
Nwachukwu, J. C., Srinivasan, S., Bruno, N. E., Parent, A. A., Hughes, T., Pollock, J. A., Gjyshi, O., Cavett, V. J., Nowak, J., Garcia-Ordoñez, R. D., et al. (2014) · eLife · doi:10.7554/elife.02057 · Cited by 139
Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities.
Ren, Z., Wang, L., Cui, J., Huoc, Z., Xue, J., Hao, C., Mao, Q., & Yang, R. (2013) · PubMed · Cited by 138
The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Höfler, H., & Becker, K.-F. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604115 · Cited by 138
Rietjens, I. M. C. M., Sotoca, A. M., Vervoort, J. J. M., & Louisse, J. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200439 · Cited by 138
Roper, J., Richardson, M. P., Wang, W. V., Richard, L. G., Chen, W., Coffee, E. M., Sinnamon, M. J., Lee, L., Chen, P., Bronson, R. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025132 · Cited by 137
Genetic aspects of inflammation and cancer
Hold, G. L., & El-Omar, E. M. (2008) · Biochemical Journal · doi:10.1042/bj20071341 · Cited by 135
Métivier, R., Stark, A., Flouriot, G., Hübner, M. R., Brand, H., Penot, G., Manu, D., Denger, S., Reid, G., Koš, M., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00746-3 · Cited by 134
Monroe, D. G., Secreto, F. J., Subramaniam, M., Getz, B. J., Khosla, S., & Spelsberg, T. C. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0381 · Cited by 133
Lao, Y., Wan, G., Liu, Z., Wang, X., Ruan, P., Xu, W., Xu, D., Xie, W., Zhang, Y., Xu, H., et al. (2014) · Autophagy · doi:10.4161/auto.28034 · Cited by 132
HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil
Körkaya, H., & Wicha, M. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3087 · Cited by 130
The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer
Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9233-4 · Cited by 130
Mitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
Regulation of glycolysis and the Warburg effect by estrogen-related receptors
Cai, Q., Lin, T., Kamarajugadda, S., & Lu, J. (2012) · Oncogene · doi:10.1038/onc.2012.221 · Cited by 129
Su, C., Chen, G. W., Lin, J. G., Wu, L. T., & Chung, J. (2006) · PubMed · Cited by 129
Yan, M., Xu, Q., Zhang, P., Zhou, X., Zhang, Z., & Chen, W. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-437 · Cited by 128
Pathology of nonalcoholic steatohepatitis
Brunt, E. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.006 · Cited by 128
Hope, C., Planutis, K., Planutiene, M., Moyer, M. P., Johal, K. S., Woo, J. S., Santoso, C., Hanson, J. A., & Holcombe, R. F. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700448 · Cited by 128
Self-citationChen, Y., Tseng, S., Lai, H., & Chen, W. (2004) · Surgery · doi:10.1016/j.surg.2004.01.017 · Cited by 127
Selective Targeting of Cancer Stem Cells: A New Concept in Cancer Therapeutics
Körkaya, H., & Wicha, M. S. (2007) · BioDrugs · doi:10.2165/00063030-200721050-00002 · Cited by 126
Han, X., & Liehr, J. G. (1994) · PubMed · Cited by 126
Elamin, M. H., Shinwari, Z., Hendrayani, S., Al‐Hindi, H., Shail, E. A., Khafaga, Y., Al‐Kofide, A., & Aboussekhra, A. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20604 · Cited by 126
Huang, C., Fan, Y.-E., Lin, C., & Hu, M. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.08.007 · Cited by 126
Miyazawa, K. (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.882 · Cited by 126
Curcumin Induces Autophagy via Activating the AMPK Signaling Pathway in Lung Adenocarcinoma Cells
Xiao, K., Jiang, J., Guan, C., Dong, C., Wang, G., Bai, L., Sun, J., Hu, C., & Bai, C. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13085fp · Cited by 125
Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin Signaling
Pai, R., Dunlap, D. Y., Qing, J., Mohtashemi, I., Hötzel, K., & French, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2325 · Cited by 125
Cyclin D1, Id1 and EMT in breast cancer
Tobin, N. P., Sims, A. H., Lundgren, K., Lehn, S., & Landberg, G. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-417 · Cited by 125
Ugolini, F., Adélaı̈de, J., Charafe‐Jauffret, E., Nguyen, C., Jacquemier, J. D., Jordan, B., Birnbaum, D., & Pébusque, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202739 · Cited by 124
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo
Sartippour, M. R., Seeram, N. P., Rao, J. Y., Moro, A., Harris, D., Henning, S. M., Firouzi, A., Rettig, M. B., Aronson, W. J., Pantuck, A. J., et al. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.2.475 · Cited by 123
Leontieva, O. V., & Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.26130 · Cited by 123
Rodova, M., Fu, J., Nall, D., Srivastava, R. K., & Shankar, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046083 · Cited by 123
Research works printed but not linked: 51
- Wang, 2013, SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis, World J Surg Oncol, 11, 12, 10.1186/1477-7819-11-12 · doi:10.1186/1477-7819-11-12
- Hede, 2006, PTEN takes center stage in cancer stem cell research, works as tumor suppressor, J Natl Cancer Inst, 98, 808, 10.1093/jnci/djj270 · doi:10.1093/jnci/djj270
- Hamburger, 1977, Primary bioassay of human myeloma stem cells, J Clin Invest, 60, 846, 10.1172/JCI108839 · doi:10.1172/jci108839
- Sánchez-García, 2009, The crossroads of oncogenesis and metastasis, N Engl J Med, 360, 297, 10.1056/NEJMcibr0808031 · doi:10.1056/nejmcibr0808031
- Tomellini, 2014, NGF and proNGF simultaneously promote symmetric self-renewal, quiescence and EMT to enlarge the breast cancer stem cell compartment, Stem Cells
- Tamari, 2014, Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity, Int J Oncol, 45, 2349, 10.3892/ijo.2014.2671 · doi:10.3892/ijo.2014.2671
- Krishnan, 2013, Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization, Cancer Metastasis Rev, 31, 605, 10.1007/s10555-012-9371-y · doi:10.1007/s10555-012-9371-y
- Fang, 2011, Imatinib plus granulocyte colony-stimulating factor in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response while on Imatinib, Case Rep Oncol, 4, 192, 10.1159/000327512 · doi:10.1159/000327512
- Danovi, 2008, Angiogenesis: turning it down a Notch, Nat Rev Cancer, 8, 572, 10.1038/nrc2448 · doi:10.1038/nrc2448
- Kakarala, 2007, Cancer stem cells: implications for cancer treatment and prevention, Cancer J, 13, 271, 10.1097/PPO.0b013e318156da4e · doi:10.1097/ppo.0b013e318156da4e
- Chen, 1997, Regulation of the ERBB-2 promoter by RBPJк and NOTCH, J Biol Chem, 272, 14110, 10.1074/jbc.272.22.14110 · doi:10.1074/jbc.272.22.14110
- Ghayad, 2010, Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients, Recent Pat Anticancer Drug Discov, 5, 29, 10.2174/157489210789702208 · doi:10.2174/157489210789702208
- Jeng, 2012, Blockade of the sonic hedgehog pathway effectively inhibits the growth of hepatoma in mice: an in vivo study, Oncology Lett, 4, 1158, 10.3892/ol.2012.935 · doi:10.3892/ol.2012.935
- Kinsell, 1948, Studies in methionine and sulfur metabolism. I. The fate of intravenously administered methionine in normal individuals and in patients with liver damage, J Clin Invest, 27, 677, 10.1172/JCI102016 · doi:10.1172/jci102016
- Mintz, 2008, The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer, Cancer, 113, 1489, 10.1002/cncr.23699 · doi:10.1002/cncr.23699
- Bolli, 2011, Current and future development of estrogen receptor ligands: applications in estrogen-related cancers, Recent Pat Endocr Metab Immune Drug Discov, 5, 210, 10.2174/187221411797265881 · doi:10.2174/187221411797265881
- Pedersen, 2005, Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII, Br J Cancer, 93, 915, 10.1038/sj.bjc.6602793 · doi:10.1038/sj.bjc.6602793
- Kuhad, 2007, Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity, J Agric Food Chem, 55, 10150, 10.1021/jf0723965 · doi:10.1021/jf0723965
- Izutani, 2012, Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells, Int J Oncol, 40, 816
- Wen, 2010, Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin, Molecules, 15, 4401, 10.3390/molecules15064401 · doi:10.3390/molecules15064401
- Choi, 2004, Kim YC Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin, Eur J Pharm Biopharm, 57, 313, 10.1016/j.ejpb.2003.11.002 · doi:10.1016/j.ejpb.2003.11.002
- Kanadzu, 2006, Dual function of epigallocatechin gallate (EGCG) in healthy human lymphocytes, Cancer Lett, 241, 250, 10.1016/j.canlet.2005.10.021 · doi:10.1016/j.canlet.2005.10.021
- Parker, 2009, Modulation of microRNA associated with ovarian cancer cells by genistein, Eur J Gynaecol Oncol, 30, 616
- Park, 2010, Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma, Cancer Lett, 292, 54, 10.1016/j.canlet.2009.11.004 · doi:10.1016/j.canlet.2009.11.004
- Mills, 1989, Cohort study of diet, lifestyle, and prostate cancer in Adventist men, Cancer, 64, 598, 10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6 · doi:10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6
- Giovannucci, 2007, Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk?, J Natl Cancer Inst, 99, 1060, 10.1093/jnci/djm048 · doi:10.1093/jnci/djm048
- Choi, 2004, Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin, Eur J Pharm Biopharm, 57, 313, 10.1016/j.ejpb.2003.11.002 · doi:10.1016/j.ejpb.2003.11.002
- Guruvayoorappan, 2008, 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation, J Exp Ther Oncol, 7, 173
- Zaidman, 2008, Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells, Mol Biol Rep, 35, 107, 10.1007/s11033-007-9059-5 · doi:10.1007/s11033-007-9059-5
- Zhang, 2011, Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line, Exp Biol Med (Maywood), 236, 714, 10.1258/ebm.2011.010347 · DOI
- Abdelwahab, 2011, Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells, Leuk Res, 35, 268, 10.1016/j.leukres.2010.07.025 · doi:10.1016/j.leukres.2010.07.025
- Tang, 2010, (−)-Epigallocatechin3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells, J Cancer Res Clin Oncol, 136, 1179, 10.1007/s00432-010-0765-3 · doi:10.1007/s00432-010-0765-3
- Cheng, 2011, Novel agents for the treatment of pancreatic adenocarcinoma, JOP, 12, 334
- Huynh, 2003, Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation, Int J Oncol, 23, 821
- Pratheeshkumar, 2012, Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways, PLoS ONE, 7, e47516, 10.1371/journal.pone.0047516 · DOI · Paper page
- Chen, 2013, Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells, FEBS Lett, 587, 3327, 10.1016/j.febslet.2013.08.022 · doi:10.1016/j.febslet.2013.08.022
- Gabellini, 2013, BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition, Carcinogenesis, 34, 2558, 10.1093/carcin/bgt242 · doi:10.1093/carcin/bgt242
- Wang, 2013, Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis, Oncotarget, 4, 1158, 10.18632/oncotarget.1093 · doi:10.18632/oncotarget.1093
- Nishinakagawa, 2010, Analysis of cell cycle arrest and apoptosis induced by RCAS1, Int J Mol Med, 25, 717
- Wong, 2009, Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages, Cancer Lett, 276, 38, 10.1016/j.canlet.2008.10.025 · doi:10.1016/j.canlet.2008.10.025
- Maeyama, 2011, Intracellular estrogen receptor-binding fragment-associated antigen 9 exerts in vivo tumor-promoting effects via its coiled-coil region, Int J Oncol, 39, 41
- Peretz, 2002, IGF1 receptor expression protects against microenvironmental stress found in the solid tumor, Radiat Res, 158, 174, 10.1667/0033-7587(2002)158[0174:IREPAM]2.0.CO;2 · doi:10.1667/0033-7587(2002)158[0174:irepam]2.0.co;2
- Dorai, 2000, Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen independent prostate cancer cells, Prostate Cancer Prostatic Dis, 3, 84, 10.1038/sj.pcan.4500399 · doi:10.1038/sj.pcan.4500399
- Park, 2002, Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53, Int J Oncol, 21, 379
- Nakamura, 2012, Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8, BMC Cell Biol, 13, 24, 10.1186/1471-2121-13-24 · doi:10.1186/1471-2121-13-24
- Yu, 2011, Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor, Oncol Rep, 26, 1197
- Chen, 2011, Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells, Hua Xi Kou Qiang Yi Xue Za Zhi, 29, 83
- Mendivil, 2011, AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways, Reprod Sci, 18, 832, 10.1177/1933719111398501 · doi:10.1177/1933719111398501
- Sayeed, 2013, Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells, PLoS ONE, 8, e67191, 10.1371/journal.pone.0067191 · doi:10.1371/journal.pone.0067191
- Breen, 2013, Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors, PLoS ONE, 8, e72407, 10.1371/journal.pone.0072407 · doi:10.1371/journal.pone.0072407
- Bryant, 2010, Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression, Arch Gynecol Obstet, 282, 677, 10.1007/s00404-010-1381-9 · doi:10.1007/s00404-010-1381-9
Cited by
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Effect of exosomal miRNA on cancer biology and clinical applications
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0897-7 · Cited by 800
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Gan, R.-Y., Li, H.-B., Sui, Z.-Q., & Corke, H. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1231168 · Cited by 438
Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Cheng, X., Xu, X., Chen, D., Zhao, F., & Wang, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.082 · Cited by 417
Metadata
- Authors
- Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., Sharma, D., Saxena, N. K., Singh, N., Vlachostergios, P. J., Guo, S., Honoki, K., Fujii, H., Georgakilas, A. G., Bilsland, A., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Boosani, C. S., Guha, G., Ciriolo, M. R., Aquilano, K., Chen, S., Mohammed, S. I., Azmi, A. S., Bhakta, D., Halicka, D., Keith, W. N., & Nowsheen, S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S25-S54
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2026982091
- Cited by
- 778
- References
- 671
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- European Commission (MC-CIG-303514)
- Associazione Italiana per la Ricerca sul Cancro (IG15221, 10636)
- National Institutes of Health (AI076535)
- University of Glasgow
- National Science Foundation
- Purdue University Center for Cancer Research
- Avon Foundation for Women
- Cancer Research UK (C301/A14762)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20125S38FA_002)
- European Cooperation in Science and Technology (CM1201)
- Ministero della Salute (GR-2011-02348047)
- Breast Cancer Research Foundation (K01DK077137, 90047965, R03DK089130, SR/FT/LS-063/2008)
- Seventh Framework Programme (CA155686, R01CA131294)
- Al Jalila Foundation (AJF201454)
- Ministry of Education, Culture, Sports, Science and Technology (24590493)
- European Regional Development Fund
- Ministerio de Ciencia e Innovación (SAF2012-32810, R01 CA109335-04A1)
- Università degli Studi Roma Tre (CLA 2013)
- Consejería de Educación, Junta de Castilla y León (BIO/SA06/13, FP7-ENV-2011)
- American Cancer Society
- Temple University
- Terry Fox Foundation (TF-36)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.